Research progress in target motion management and toxicity of MR-guided stereotactic body radiation therapy
10.3760/cma.j.cn113030-20240530-00214
- VernacularTitle:磁共振引导立体定向放疗靶区运动管理及不良反应研究进展
- Author:
Menglin ZHANG
1
;
Min LIU
;
Yimin LI
;
Jinyi LANG
;
Jun YIN
Author Information
1. 川北医学院临床医学院，南充 637000
- Publication Type:Journal Article
- Keywords:
Radiotherapy;
Magnetic resonance-guided radiotherapy;
Fractional motion;
Stereotactic body radiation therapy;
Radiation therapy-related toxicity
- From:
Chinese Journal of Radiation Oncology
2025;34(1):36-43
- CountryChina
- Language:Chinese
-
Abstract:
Stereotactic radiation therapy is a crucial approach in the treatment of tumors. However, the precision of stereotactic radiation therapy is influenced by important factors such as fractional tumor motion, image-guided resolution, and the utilization of adaptive techniques. Different image-guided methods and motion management strategies exhibit varying degrees of control over radiation-related toxicity. With the clinical application of magnetic resonance accelerator, it is still unclear whether its excellent soft tissue imaging contrast, adaptive radiotherapy technology, and real-time motion management of the moving target can bring better toxicity control for patients. Hence, the advantages of magnetic resonance accelerator in mitigating radiation-related toxicity, its clinical applications, and the reported post-treatment toxic reactions were comprehensively reviewed in this article.
